ConductScience.org, home

Paper39212337

Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome.

Mensah JA and 6 others. Epilepsia, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome. Papers, record 39212337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39212337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome.
PubMed
Journal
Epilepsia
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.18, provisional
iCite
Revised in PubMed
2025-10-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mensah JAJeffrey Ahttps://orcid.org/0000-0001-7026-9329
2Johnson KKristina
3Freeman TTia
4Reilly CAChristopher Ahttps://orcid.org/0000-0002-5006-1982
5Rower JEJoseph Ehttps://orcid.org/0000-0003-3629-7902
6Metcalf CSCameron Shttps://orcid.org/0000-0002-1510-0405
7Wilcox KSKaren Shttps://orcid.org/0000-0003-2660-8826

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epilepsies, MyoclonicMajor topic
Disease Models, AnimalMajor topic
ClobazamMajor topic
AnticonvulsantsMajor topic
Valproic AcidMajor topic
DioxolanesMajor topic
CannabidiolMajor topic
HyperthermiaMajor topic
Animals
Mice
Drug Therapy, Combination
NAV1.1 Voltage-Gated Sodium Channel
Seizures
Dose-Response Relationship, Drug
Mice, Transgenic
Male
Fenfluramine

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
75N95022C00007NIDA NIH HHSUnited StatesPubMed
HHSN271201600048CNIDA NIH HHSUnited StatesPubMed
Donald R. Gehlert Fellowship, University of Utah College of PharmacyPubMed
HHS 75N95022C00007National Institute of Neurological Disorders and Stroke, Epilepsy Therapy Screening Program, National Institutes of Health, and Department of Health and Human ServicesPubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138427284Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis.Epilepsia Open2024https://conductscience.org/library/papers/38427284PubMed
227264138Treatment of Dravet Syndrome.Can J Neurol Sci2016https://conductscience.org/library/papers/27264138PubMed
331519475Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.Epilepsy Behav2019https://conductscience.org/library/papers/31519475PubMed
430509294Reviewing the role of healthy volunteer studies in drug development.J Transl Med2018https://conductscience.org/library/papers/30509294PubMed
526651971Cannabinoids and Cytochrome P450 Interactions.Curr Drug Metab2016https://conductscience.org/library/papers/26651971PubMed
622743350Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.Ther Drug Monit2012https://conductscience.org/library/papers/22743350PubMed
731862249Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.Lancet2019https://conductscience.org/library/papers/31862249PubMed
831790543Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.JAMA Neurol2020https://conductscience.org/library/papers/31790543PubMed
930638257Ascertaining the epidemiology, patient flow and disease management for Dravet syndrome in Spain.Rev Neurol2019https://conductscience.org/library/papers/30638257PubMed
1032054370Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.Expert Opin Drug Metab Toxicol2020https://conductscience.org/library/papers/32054370PubMed
1134882995Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe.Epilepsia Open2022https://conductscience.org/library/papers/34882995PubMed
1211736863In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).Br J Clin Pharmacol2001https://conductscience.org/library/papers/11736863PubMed
1312954800Interaction of antiepileptic drugs with human P-glycoprotein in vitro.J Pharmacol Exp Ther2003https://conductscience.org/library/papers/12954800PubMed
1421463272The core Dravet syndrome phenotype.Epilepsia2011https://conductscience.org/library/papers/21463272PubMed
1515526956Severe myoclonic epilepsy in infancy: toward an optimal treatment.J Child Neurol2004https://conductscience.org/library/papers/15526956PubMed
1631549357Recent Advances in the Drug Treatment of Dravet Syndrome.CNS Drugs2019https://conductscience.org/library/papers/31549357PubMed
1722718676Dose-finding designs: the role of convergence properties.Int J Biostat2011https://conductscience.org/library/papers/22718676PubMed
1834093420Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox-Gastaut Syndrome.Front Neurol2021https://conductscience.org/library/papers/34093420PubMed
1926183863Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.Brain Dev2016https://conductscience.org/library/papers/26183863PubMed
2034130255Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.Epilepsy Res2021https://conductscience.org/library/papers/34130255PubMed

See all 51 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
40972134Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments.J Anal Toxicol2026https://conductscience.org/library/papers/40972134PubMed
40586768Development of a preclinical testing platform for clinically relevant therapy for Dravet syndrome.Epilepsia2025https://conductscience.org/library/papers/40586768PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39212337

GET https://conductscience.org/api/papers/v1/39212337/references?page=2